3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Recurrence
1
Pheochromocytoma
1
Paraganglioma
1
Neoplasms by Histologic Type
1
Neoplasms
1
Lymphoproliferative Disorders
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma
1
Lymphatic Diseases
1
Immunoproliferative Disorders
1
Immune System Diseases
1
Gastro-enteropancreatic neuroendocrine tumor
1
AIDS-Related Complex
1
Interventions
Everolimus
16
Octreotide
6
pembrolizumab
5
lanreotide
5
Sunitinib
5
Magnetic Resonance Spectroscopy
5
gallium Ga 68 dotatate
4
cabozantinib
4
Nivolumab
4
Carboplatin
4
telotristat ethyl
3
lenvatinib
3
arginyllysine
3
Specimen Handling
3
Etoposide
3
Erlotinib Hydrochloride
3
Bevacizumab
3
surufatinib
2
pazopanib
2
pasireotide
2
lutetium Lu 177 dotatate
2
amino-acid, glucose, and electrolyte solution
2
X-Rays
2
Temozolomide
2
Sorafenib
2
Phantoms, Imaging
2
Paclitaxel
2
Oxaliplatin
2
Ipilimumab
2
Doxorubicin
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Neuroendocrine Tumors
×
Lutetium
×
Clear all
No trials found.